海得控制(002184.SZ):公司未涉及人形機器人產品的研究
格隆匯5月27日丨海得控制(002184.SZ)在互動平臺表示,公司主營業務數字化一翼中的工業電氣自動化與工業信息化業務中包含爲機械複雜計算及運動控制的軟硬件產品的研發和產品(中型冗餘PLC、邊緣控制器、SCADA軟件、智能網管軟件等)。目前,公司未涉及人形機器人產品的研究。公司常年積累的相關自動化、信息化等技術可複用於機器人產業的發展。工業機器人作爲各種執行機構的一種接入公司“二化”融合解決方案中的控制層和數據交互層。公司在冶金、管廊、港口等行業的開展的無人化智能系統應用需要在適應性、複製性、迭代性等方面繼續融合包括智控、智算、智顯等技術,幫助用戶逐步實現與提高系統智能化綜合水平。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.